Logo of Invion (ASX:IVX)Latest Invion (ASX:IVX) News

Page 3
Page 3 of 3

Invion’s INV043 Shows Safety and Early Promise in Skin Cancer Trial

Invion Limited reports no adverse events and early lesion reduction in its Phase I/II non-melanoma skin cancer trial, advancing to dose optimization.
Ada Torres
29 May 2025

Invion Advances Photosoft Trials, Secures $2M to Expand Cancer Pipeline

Invion Limited has progressed its Photosoft clinical programs with new patient dosing and an expanded collaboration with Hanlim Pharm, backed by a successful $2 million share placement to accelerate development.
Ada Torres
30 Apr 2025

Invion Advances Cancer Trials with Key Milestones and New Funding

Invion Limited has marked significant progress in its cancer treatment pipeline, dosing the first patient in a pivotal skin cancer trial and reporting encouraging prostate cancer results, while securing fresh funding to support ongoing development.
Victor Sage
31 Jan 2025